Johnson & Johnson (JNJ)
Johnson & Johnson to Acquire Firefly Bio, Inc. to Expand Oncology Pipeline with Novel Degrader Antibody Conjugate Platform
Johnson & Johnson to Acquire Firefly Bio, Inc. to Expand Oncology Pipeline with Novel Degrader Antibody Conjugate Platform
Global Industrial to Showcase Workplace Safety Solutions at ASSP Safety 2026
FIS Builds Alliance with Fuse to Give Auto and Equipment Lenders a Faster Path to Modern Origination
Xylem Expands Long-Term Water Partnership with Dow
Ocean Power Technologies Demonstrates Strong Field Performance from DHS Deployment and Advances Operational Scalability
MediciNova Receives Notice of Allowance for New Patent Covering Use of MN-166 in Combination with Anti-PD-1 Immune Checkpoint Inhibitor for Glioblastoma Treatment
ASML reports transactions under its current share buyback program
Vaxart Urges Shareholders to Vote “FOR” ALL Six of the Company’s Highly Qualified Director Nominees on the WHITE Proxy Card TODAY
Teva’s Data on AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets Highlight Long-Term Advances in Tardive Dyskinesia Treatment and Care
AbbVie Presents New Data Across Its Blood Cancer Portfolio at EHA 2026